<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; why</title>
	<atom:link href="http://www.tapanray.in/tag/why/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Drugs From The Same Indian Plant: Safe For Europe, Unsafe For America, Why?</title>
		<link>http://www.tapanray.in/drugs-from-the-same-indian-plant-safe-for-europe-unsafe-for-america-why/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=drugs-from-the-same-indian-plant-safe-for-europe-unsafe-for-america-why</link>
		<comments>http://www.tapanray.in/drugs-from-the-same-indian-plant-safe-for-europe-unsafe-for-america-why/#comments</comments>
		<pubDate>Mon, 09 Jun 2014 00:00:37 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[cGMP]]></category>
		<category><![CDATA[commissioner]]></category>
		<category><![CDATA[conspiracy]]></category>
		<category><![CDATA[Diovan]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[EMA]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Hamburg]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Lipitor]]></category>
		<category><![CDATA[Margaret]]></category>
		<category><![CDATA[nexium]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[plant]]></category>
		<category><![CDATA[Ranbaxy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulators]]></category>
		<category><![CDATA[safe]]></category>
		<category><![CDATA[Sun]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Theory]]></category>
		<category><![CDATA[Toansa]]></category>
		<category><![CDATA[unsafe]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[USFDA]]></category>
		<category><![CDATA[why]]></category>
		<category><![CDATA[wockhardt]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=5493</guid>
		<description><![CDATA[Good number of stories on US-FDA banning several drug manufacturing facilities of major domestic players of India over serious quality related issues, have been doing the rounds since about a year and almost at a regular interval. The quagmire has &#8230; <a href="http://www.tapanray.in/drugs-from-the-same-indian-plant-safe-for-europe-unsafe-for-america-why/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/drugs-from-the-same-indian-plant-safe-for-europe-unsafe-for-america-why/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Have the successive ‘Drug Policies’ of India delivered? If not, why not?</title>
		<link>http://www.tapanray.in/have-the-successive-drug-policies-of-india-delivered-if-not-why-not/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=have-the-successive-drug-policies-of-india-delivered-if-not-why-not</link>
		<comments>http://www.tapanray.in/have-the-successive-drug-policies-of-india-delivered-if-not-why-not/#comments</comments>
		<pubDate>Mon, 17 Jan 2011 01:00:45 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[branded]]></category>
		<category><![CDATA[cheap]]></category>
		<category><![CDATA[delivered]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Have]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[If]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policies]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[successive]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[why]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=314</guid>
		<description><![CDATA[January 11, 2011 edition of ‘The Lancet’ in its article titled, “Financing health care for all: challenges and opportunities&#8221; commented as follows: “India&#8217;s health financing system is a cause of and an exacerbating factor in the challenges of health inequity, &#8230; <a href="http://www.tapanray.in/have-the-successive-drug-policies-of-india-delivered-if-not-why-not/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/have-the-successive-drug-policies-of-india-delivered-if-not-why-not/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘Swine Flu’ – why create so much of scare to disturb public life?</title>
		<link>http://www.tapanray.in/swine-flu-why-create-so-much-of-scare-to-disturb-public-life/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=swine-flu-why-create-so-much-of-scare-to-disturb-public-life</link>
		<comments>http://www.tapanray.in/swine-flu-why-create-so-much-of-scare-to-disturb-public-life/#comments</comments>
		<pubDate>Thu, 13 Aug 2009 01:00:51 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[create]]></category>
		<category><![CDATA[disturb]]></category>
		<category><![CDATA[Flu]]></category>
		<category><![CDATA[life]]></category>
		<category><![CDATA[much]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[scare]]></category>
		<category><![CDATA[so]]></category>
		<category><![CDATA[Swine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[why]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=809</guid>
		<description><![CDATA[Why has so much of scare been created on ‘Swine Flu’ in India? Who are responsible for creating and spreading such panic?Any attempted answers to these question perhaps will remain baffling to many of us when we read that out &#8230; <a href="http://www.tapanray.in/swine-flu-why-create-so-much-of-scare-to-disturb-public-life/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/swine-flu-why-create-so-much-of-scare-to-disturb-public-life/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why is China surpassing India almost in all the verticals of Pharmaceutical industry?</title>
		<link>http://www.tapanray.in/why-is-china-surpassing-india-almost-in-all-the-verticals-of-pharmaceutical-industry/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=why-is-china-surpassing-india-almost-in-all-the-verticals-of-pharmaceutical-industry</link>
		<comments>http://www.tapanray.in/why-is-china-surpassing-india-almost-in-all-the-verticals-of-pharmaceutical-industry/#comments</comments>
		<pubDate>Mon, 04 May 2009 05:00:34 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[almost]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[surpassing]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[verticals]]></category>
		<category><![CDATA[why]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=898</guid>
		<description><![CDATA[To make India a major hub for Pharmaceutical outsourcing of all types, the country has all the required ingredients. India has indeed the potential to be a contender for global supremacy, in these fast growing sectors. However, despite all these, &#8230; <a href="http://www.tapanray.in/why-is-china-surpassing-india-almost-in-all-the-verticals-of-pharmaceutical-industry/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/why-is-china-surpassing-india-almost-in-all-the-verticals-of-pharmaceutical-industry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Growing menace of counterfeit drugs in India: why is the domestic pharmaceutical industry still so apprehensive with the new Amendments of the ACT?</title>
		<link>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2</link>
		<comments>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/#comments</comments>
		<pubDate>Wed, 29 Apr 2009 00:30:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Amendments]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[so]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[why]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=903</guid>
		<description><![CDATA[The growing menace of Counterfeit drugs has remained a serious threat to the healthcare space of India. Do we have any credible data to assess the magnitude of this menace in India? No we do not have, as yet. At &#8230; <a href="http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
